← Leaderboards
Ryan C Fields
Washington University
$14,321,445
Attributed
$19,581,369
Total exposure
18
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.3M · FY2014–25$20M$15M$10M$5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$51,525,224 · 23
By mechanism
U2C$24,170,929 · 6
U54$11,186,399 · 5
R01$6,618,808 · 3
P50$5,129,778 · 4
U01$2,764,607 · 2
R21$1,231,650 · 2
Top collaborators
- Li Ding23 shared
- Richard A Flavell8 shared
- Feng Chen6 shared
- Graham A Colditz6 shared
- Bettina F. Drake6 shared
- William E Gillanders6 shared
- Samuel Achilefu5 shared
- Christopher A Maher5 shared
Most similar at Washington University
Same institution · by research overlap
- Li Ding$30,836,856
- Feng Chen$14,745,479
- Bettina F. Drake$4,193,535
- Christopher A Maher$7,094,981
- Helen M Piwnica-Worms$9,529,923
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsTumorResearch PersonnelUniversitiesWashingtonTissuesCollaborationsGenomicsSamplingEnsureProgramsSuccessFutureResourcesSpecimenOperative Surgical ProceduresInfrastructureProspectiveEvaluationInstitutionNeoplasm MetastasisMedical SchoolsBiopsyTranslational Research
Grant awards (72)
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)$1,500,000
U54 · FY2025 · AG
Participant Engagement Unit$490,118
U2C · FY2025 · CA · contact PI
The Impact of Metastatic Site On Dendritic Cell-Driven Tumor Immunity$461,446
U01 · FY2025 · CA
Core B: Biospecimen Core$266,752
P50 · FY2025 · CA · contact PI
Developmental Research Program$243,179
P50 · FY2025 · CA · contact PI
WU-SN-TMC Biospecimen Core$190,310
U54 · FY2025 · AG · contact PI
PDX Core$174,919
U54 · FY2025 · CA · contact PI
The role of RAMS11 in colorectal cancer progression and treatment resistance$85,153
R01 · FY2025 · CA
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)$1,500,000
U54 · FY2024 · AG
Washington University PDX Development and Trial Center$1,075,484
U54 · FY2024 · CA
Human Prostate Tumor Atlas Center$1,032,520
U01 · FY2024 · CA
The Impact of Metastatic Site On Dendritic Cell-Driven Tumor Immunity$612,272
U01 · FY2024 · CA
Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model$569,047
R01 · FY2024 · CA · contact PI
Participant Engagement Unit$533,351
U2C · FY2024 · CA · contact PI
Core B: Biospecimen Core$253,465
P50 · FY2024 · CA · contact PI
Developmental Research Program$233,452
P50 · FY2024 · CA · contact PI
WU-SN-TMC Biospecimen Core$188,312
U54 · FY2024 · AG · contact PI
PDX Core$165,970
U54 · FY2024 · CA · contact PI
The role of RAMS11 in colorectal cancer progression and treatment resistance$85,153
R01 · FY2024 · CA
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)$3,109,346
U2C · FY2023 · CA
Washington University SPORE in Pancreatic Cancer$2,065,042
P50 · FY2023 · CA
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)$1,500,000
U54 · FY2023 · AG
Washington University PDX Development and Trial Center$1,133,597
U54 · FY2023 · CA
WASHINGTON UNIVERSITY HUMAN TUMOR ATLAS RESEARCH CENTER$874,677
U2C · FY2023 · CA
The Impact of Metastatic Site On Dendritic Cell-Driven Tumor Immunity$658,369
U01 · FY2023 · CA
Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model$587,012
R01 · FY2023 · CA · contact PI
The role of RAMS11 in colorectal cancer progression and treatment resistance$567,677
R01 · FY2023 · CA
StARR Program in Cross-Disciplinary Oncology Clinician-Scientist Training$423,053
R38 · FY2023 · CA · contact PI
Participant Engagement Unit$388,967
U2C · FY2023 · CA · contact PI
Core B: Biospecimen Core$244,765
P50 · FY2023 · CA · contact PI
Developmental Research Program$230,194
P50 · FY2023 · CA · contact PI
PDX Core$195,930
U54 · FY2023 · CA · contact PI
WU-SN-TMC Biospecimen Core$186,073
U54 · FY2023 · AG · contact PI
Biospecimen Acquisition, Processing, and Classification Unit$169,727
U2C · FY2023 · CA · contact PI
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)$4,382
U2C · FY2023 · CA
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)$3,831,299
U2C · FY2022 · CA
Washington University Human Tumor Atlas Research Center$1,767,704
U2C · FY2022 · CA
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)$1,499,999
U54 · FY2022 · AG
Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model$587,011
R01 · FY2022 · CA · contact PI
The role of RAMS11 in colorectal cancer progression and treatment resistance$558,058
R01 · FY2022 · CA
Participant Engagement Unit$492,617
U2C · FY2022 · CA · contact PI
Biospecimen Acquisition, Processing, and Classification Unit$265,733
U2C · FY2022 · CA · contact PI
WU-SN-TMC Biospecimen Core$183,841
U54 · FY2022 · AG · contact PI
Admin-Core-001$28,540
U2C · FY2022 · CA
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)$28,540
U2C · FY2022 · CA
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)$3,543,660
U2C · FY2021 · CA
Washington University Human Tumor Atlas Research Center$1,771,877
U2C · FY2021 · CA
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)$1,500,000
U54 · FY2021 · AG
Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model$598,999
R01 · FY2021 · CA · contact PI
Participant Engagement Unit$563,492
U2C · FY2021 · CA · contact PI
The role of RAMS11 in colorectal cancer progression and treatment resistance$551,689
R01 · FY2021 · CA
Biospecimen Acquisition, Processing, and Classification Unit$267,970
U2C · FY2021 · CA · contact PI
WU-SN-TMC Biospecimen Core$191,964
U54 · FY2021 · AG · contact PI
Washington University Human Tumor Atlas Research Center$1,771,881
U2C · FY2020 · CA
Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model$612,841
R01 · FY2020 · CA · contact PI
Core B: Biospecimen Core$331,138
P50 · FY2020 · CA · contact PI
Biospecimen Acquisition, Processing, and Classification Unit$266,600
U2C · FY2020 · CA · contact PI
Washington University Human Tumor Atlas Research Center$1,714,176
U2C · FY2019 · CA
Towards True Precision Oncology: Validation of a Comprehensively Humanized, Autologous Mouse Model$584,722
R01 · FY2019 · CA · contact PI
Core B: Biospecimen Core$308,603
P50 · FY2019 · CA · contact PI
Advancing Cancer Biology, Diagnostics and Therapeutics Outside of the Patient: Creation of a Novel, Autologous, Ex Vivo, Vascularized Model of the Tumor Microenvironment$295,850
R21 · FY2019 · CA · contact PI
Biospecimen Acquisition, Processing, and Classification Unit$264,423
U2C · FY2019 · CA · contact PI
Washington University Human Tumor Atlas Research Center$1,752,191
U2C · FY2018 · CA
Towards True Precision Oncology: Validation of a Comprehensively Humanized, Autologous Mouse Model$588,621
R01 · FY2018 · CA · contact PI
Core B: Biospecimen Core$331,718
P50 · FY2018 · CA · contact PI
Advancing Cancer Biology, Diagnostics and Therapeutics Outside of the Patient: Creation of a Novel, Autologous, Ex Vivo, Vascularized Model of the Tumor Microenvironment$305,000
R21 · FY2018 · CA · contact PI
Biospecimen Acquisition, Processing, and Classification Unit$269,658
U2C · FY2018 · CA · contact PI
Towards True Precision Oncology: Validation of a Comprehensively Humanized, Autologous Mouse Model$642,825
R01 · FY2017 · CA · contact PI
Core B: Biospecimen Core$300,637
P50 · FY2017 · CA · contact PI
Core B: Biospecimen Core$320,833
P50 · FY2016 · CA · contact PI
EVALUATION OF POSITRON EMISSION TOMOGRAPHY-MAGNETIC RESONANCE IMAGING (PET-MRI)$315,400
R21 · FY2015 · CA · contact PI
EVALUATION OF POSITRON EMISSION TOMOGRAPHY-MAGNETIC RESONANCE IMAGING (PET-MRI)$315,400
R21 · FY2014 · CA · contact PI